BOMELINN® is a dietary supplement containing bromelain, a patented complex mixture of proteolytic enzymes isolated from the pineapple peel (Ananas comosus) that have a strong effect against inflammation, swelling and pain, as well as improving the breakdown of secretions and fibrin while modulating the immune system.
The BOMELINN® product contains the patented formulation Bromeyal®, which has a beneficial effect on inflammation, pain and swelling that accompany the diseases of the locomotor, reproductive and respiratory systems, as well as after surgical interventions.
In which conditions is the use of the product BOMELINN® recommended?
Reduction of swelling, pain and inflammation in the following conditions:
Osteoarthritis, rheumatoid arthritis
For sports injuries (fractures, sprains, dislocations)
After surgical and dental interventions
In mastitis, endometriosis and after giving birth
In people with prostate inflammationTo facilitate breathing and break down secretions in case of inflammation of the nose, sinuses and bronchi
With antibiotic therapy
In people with indigestion
Why BOMELINN®?
Reduces swelling, pain and inflammation
Accelerates the resorption of oedema and hematoma
Shortens recovery after trauma or intervention
Improves the quality of life
Complementary therapy with antibiotics and analgesics
Comfortable administration – one tablet a day
What do BOMELINN® contain?
| Composition | One tablet (daily dose) |
|---|---|
| Bromelain (Bomeyal®), 2500 GDU/g* | 500 mg |
* GDU/g (gelatin digesting units) – Gelatin digestion unit per gram.
Bromeyal® represents a patented formulation which contains bromelain, which is obtained through a unique proprietary multi-step aqueous extraction process from pineapple peel. Specific production technology prevents enzyme denaturation and decomposition of active ingredients of bromelain after passing through the gastro-intestinal tract.
The proteolytic fragments of the patented Bromeyal® formulation exert an anti-inflammatory activity before and after the simulation of gastro-intestinal digestion, without the need to use enteric coating technology (gastro-resistant capsule or tablet).
Indication and length of administration:
| INDICATION | LENGTH OF ADMINISTRATION |
|---|---|
| Osteoarthritis | 1 tablet a day, between meals, for one month. |
| Rheumatoid arthritis | |
| Sports injuries (fractures, dislocations, sprains) | 1 tablet a day, between meals, for 2 weeks. |
| After surgical interventions | |
| Rhinitis, sinusitis, bronchitis | |
| Dental interventions | |
| Mastitis | |
| After giving birth | |
| Endometriosis | 1 tablet a day, between meals, for 6 months. |
| Inflammation of the prostate | 1 tablet a day, between meals, during administration of antibiotic therapy. |
| With antibiotic therapy | |
| Dyspepsia | 1 tablet a day, during a meal. |
*The maximum length of continuous administration is 6 months.
Notes and warnings: The recommended daily dose must not be exceeded. The product is not intended for people under the age of 18, pregnant women, nursing mothers, or people hypersensitive to any of the product’s ingredients. People who use medicines should consult a doctor before use. Special caution is required for people on anticoagulant and antiplatelet therapy.
Presentation: 15 tablets.